FDA Inspection 887204 — Servy Institute For Reproductive Endocrinology
The FDA completed an inspection of Servy Institute For Reproductive Endocrinology on Jul 11, 2014 in Augusta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 11, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Augusta, GA (United States)